Immunologic Mechanisms and Therapy in Multiple Sclerosis (Q40433260)

20 September 2017

1 reference

title

Immunologic mechanisms and therapy in multiple sclerosis (English)

1 reference

20 September 2017

Immunologic Mechanisms and Therapy in Multiple Sclerosis (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

30 May 2024

0 references

1

Hafler DA

1 reference

20 September 2017

H. L. Weiner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590822

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7590822

30 May 2024

publication date

1 April 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1995.tb00066.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-065X.1995.tb00066.x

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

30 May 2024

published in

Immunological Reviews

1 reference

20 September 2017

volume

144

1 reference

20 September 2017

page(s)

75-107

1 reference

Evidence for a differential avidity model of T cell selection in the thymus

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Immunologic studies of patients with chronic encephalitis induced by post-exposure Semple rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Tumor necrosis factor identified in multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

T cell receptor antagonist peptides induce positive selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Mechanisms of self tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Peripheral T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

The regulation of immune responses to dietary protein antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

The distinctive specificity of antigen-specific suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Phosphorylation on basic amino acids in myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

In vivo chemical modification of proteins (post-translational modification).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

T-cell recognition of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Stigma Variations: Observations On Suppressor T Cells And Leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Identification of the region of T cell receptor β chain that interacts with the self-superantigen MIs-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

In vivo competition between self peptides and foreign antigens in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Astrocytes present myelin basic protein to encephalitogenic T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

A comparison of regulatory cells in spinal fluid and blood in patients with multiple sclerosis and other neurologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Oral tolerance in experimental autoimmune encephalomyelitis: serum and salivary antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Oral desensitization in Rh disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Immune responses of human adults after oral and parenteral exposure to bovine serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00066.X

T cells responsive to myelin basic protein in patients with multiple sclerosis

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals

30 May 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

30 May 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Heterogeneity of human T lymphocytes to bind sheep red blood cells in multiple sclerosis patients and controls

30 May 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Stigma variations: observations on suppressor T cells and leprosy

30 May 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

T-T cell interactions are mediated by adhesion molecules

30 May 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

30 May 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans

30 May 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Remarks on a Cutaneous Affection, prodused by cretain Poisonous Vagetables

30 May 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand

30 May 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation

30 May 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

30 May 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity

30 May 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Immunosuppression with monoclonal antibodies in multiple sclerosis

30 May 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness

30 May 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo

30 May 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis

30 May 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides

30 May 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

30 May 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.

30 May 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases

30 May 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Immunosuppression caused by antigen feeding. I. Evidence for the activation of a feedback suppressor pathway in the spleens of antigen-fed mice

30 May 2024

63

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides

30 May 2024

66

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin

30 May 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

30 May 2024

70

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen

30 May 2024

78

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.

30 May 2024

84

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis

30 May 2024

87

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Lymphokine production by human T cells in disease states

30 May 2024

91

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events

30 May 2024

92

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat

30 May 2024

94

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen

30 May 2024

95

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

A cell culture model for T lymphocyte clonal anergy

30 May 2024

97

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Acquisition of lymphokine-producing phenotype by CD4+ T cells

30 May 2024

98

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Dominance and crypticity of T cell antigenic determinants

30 May 2024

100

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein

30 May 2024

104

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

30 May 2024

111

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis

30 May 2024

112

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium

30 May 2024

114

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand

30 May 2024

116

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

30 May 2024

119

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions

30 May 2024

121

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

30 May 2024

124

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

30 May 2024

127

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00066.X

30 May 2024

Identifiers

1 reference

20 September 2017

1 reference